Return to homepagePandemic Pact

COVID-19 vaccine funding for the COVAX Advance Market Commitment (AMC)

  • Funded by Foreign, Commonwealth & Development Office (FCDO)
  • Total publications:0 publications

Grant number: GB-GOV-1-301271

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2021

  • Known Financial Commitments (USD)

    $680,642,133.3

  • Funder

    Foreign, Commonwealth & Development Office (FCDO)

  • Principal Investigator

    N/A

  • Research Location

    International

  • Lead Research Institution

    International Finance Facility for Immunisation

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Vaccine logistics and supply chains and distribution strategies

  • Special Interest Tags

    N/A

  • Study Type

    Not applicable

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The UK is supporting early access to COVID-19 vaccines for the world'Äôs poorest countries through a commitment to the COVAX AMC (Advance Market Commitment) using the International Financing Facility for Immunisation (IFFIm). This contribution will support access to at least 1 billion vaccine doses during 2021 for 92 developing countries. This will contribute to ending the acute phase of the COVID-19 pandemic by reducing morbidity and mortality. Supporting access for the world poorest countries demonstrates UK commitment to vaccine multilateralism and supports the UK'Äôs international objectives of bringing the pandemic under control and supporting global economic recovery.